- Price
- $23.10
- Day
- +1.27%
- Mkt Cap
- $24.93B
- 52W Range
- $16.47 – $24.07
- Volume
- 6.26M
- Beta
- 1.02
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
CLEVELAND, Aug. 4, 2026 /PRNewswire/ -- KeyCorp (NYSE: KEY) announced today that it has completed its previously-announced acquisition of Clearwater Corporate Finance LLP ("Clearwater UK"), a leading UK-based middle market investment banking advisory firm. "Completing this acquisition marks an important step in expanding our global advisory platform," said Randy Paine, President of Key Institutional Bank.
Read full article
CLEVELAND, July 31, 2026 /PRNewswire/ -- KeyCorp (NYSE: KEY) today announced plans to host conference calls to review quarterly financial results on the following dates: First quarter 2027 – Tuesday, April 20, 2027, at 8 a.m. ET Second quarter 2027 – Tuesday, July 20, 2027, at 8 a.m.
Read full article
Retiring at 60 with a five-figure monthly paycheck sounds like it requires decades of maxing every tax-advantaged account you own, but a taxable brokerage and the right yield strategy can tell a very different story for a 44-year-old with 16 years on the clock.
Read full article
Verizon , Kinder Morgan, Regions Financial, and KeyCorp are the four buyable Barron's Better Bets Dogs, offering high, 'safest' dividends at fair prices. Analyst forecasts project net gains of 9.62% to 21.97% for top BBB Dogs by July 2027, with average net 13.68% on the top ten. Six BBB Dogs show negative free cash flow margins, making their dividends potentially unsafe; Pfizer, ONEOK, Mid-America Apartment, Federal Realty, Williams Companies, and Entergy are flagged.
Read full article
Replacing a Social Security check with dividend income sounds straightforward until you realize the yield you chase changes the capital required by more than a million dollars. The tier you pick carries tradeoffs most income investors only discover after the fact.
Read full article
Andra AP fonden lessened its holdings in shares of KeyCorp (NYSE: KEY) by 34.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 103,539 shares of the financial services provider's stock after selling 53,761 shares during the period. Andra
Read full article
Halozyme Therapeutics is at a new high on Friday with earnings due on Aug. 6. Philip Morris International and KeyCorp are also at highs.
Read full article
KeyCorp delivered a decent Q2 report, beating earnings estimates with robust net interest income and expanding fee businesses. KeyCorp's fee-based growth strategy, including payments and investment services, has further support the bank's growth in the second-quarter. Shares offer an attractive 3.6% dividend yield and trade at a 1.43x price-to-book, with upside revaluation potential versus peers.
Read full article
On CNBC's “Mad Money Lightning Round,” Jim Cramer said that although he likes Truist Financial Corporation (NYSE:TFC), he prefers KeyCorp (NYSE:KEY) to Truist.
Read full article
California Public Employees Retirement System boosted its position in shares of KeyCorp (NYSE: KEY) by 4.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,766,616 shares of the financial services provider's stock after purchasing an additional 78,529 shares during the quarter.
Read full article
KeyCorp beats Q2 earnings estimates as higher net interest and fee income, lower provisions, and loan growth lift the results despite rising expenses.
Read full article
The headline numbers for KeyCorp (KEY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read full article